Licaminlimab for dry eye syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Apr 2026: Trial started, NCT07548632
  2. 23 Apr 2026: Trial registered, NCT07548632

The trials

NCT07548632: A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

State
Under way
Phase
Phase 2 and Phase 3
People
160 planned
Started
16 Apr 2026
Primary completion
Dec 2026
Arms
licaminlimab
Results
None posted
  1. 16 Apr 2026: Trial started
  2. 23 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.